Abstract
Autophagy is the mass degradation system that removes long-lived proteins and malfunctioning organelles within the cell. Dysfunctional autophagic processes can cause various diseases such as cancer and neurodegenerative disorders, but the underlying mechanisms responsible for such events remain undefined. Small molecules that control autophagy could be powerful tools to reveal autophagy mechanisms, and to develop treatments for autophagy-related diseases including Alzheimer's disease, Parkinson's disease and various cancer types. This review discusses the small molecules that have been identified to control autophagy and how they can be used to understand signaling pathways important for autophagy in the context of chemical genomics.
Original language | English |
---|---|
Pages (from-to) | 1881-1889 |
Number of pages | 9 |
Journal | Archives of pharmacal research |
Volume | 33 |
Issue number | 12 |
DOIs | |
Publication status | Published - 2010 Dec |
Bibliographical note
Funding Information:This study was partly supported by grants from the
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Drug Discovery
- Organic Chemistry